|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 47/50 |
| (11) | Patento numeris | 2780039 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 12787111.9 |
| Europos patento paraiškos padavimo data | 2012-11-07 | |
| (97) | Europos patento paraiškos paskelbimo data | 2014-09-24 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-11-29 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/IB2012/056224 |
| Data | 2012-11-07 |
| (87) | Numeris | WO 2013/072813 |
| Data | 2013-05-23 |
| (30) | Numeris | Data | Šalis |
| 201161561255 P | 2011-11-17 | US | |
| 201261676423 P | 2012-07-27 | US |
| (72) |
DOROSKI, Matthew David, US
MADERNA, Andreas, US
O`DONNELL, Christopher John, US
SUBRAMANYAM, Chakrapani, US
VETELINO, Beth Cooper, US
DUSHIN, Russell George, US
STROP, Pavel, US
GRAZIANI, Edmund, Idris, US
|
| (73) |
Pfizer Inc.,
235 East 42nd Street, New York, NY 10017,
US
|
| (54) | CYTOTOXIC PEPTIDES AND ANTIBODY DRUG CONJUGATES THEREOF |
| CYTOTOXIC PEPTIDES AND ANTIBODY DRUG CONJUGATES THEREOF |